An Evaluation of the Efficacy and Safety of Tapentadol Oral Solution in the Treatment of Post-operative Acute Pain Requiring Opioid Treatment in Pediatric Subjects Aged From Birth to Less Than 18 Years Old
Phase of Trial: Phase III
Latest Information Update: 10 Jun 2019
Price : $35 *
At a glance
- Drugs Tapentadol (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Grunenthal; Janssen
- 01 Apr 2019 Status changed from recruiting to completed.
- 10 Dec 2018 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
- 10 Dec 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2019.